ARDX
ARDELYX, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.09
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- 44.29x
- P/E 2026E
- —
- P/E 2027E
- 12.23x
- P/E 2028E
- 3.81x
- P/S forward
- 1.45x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.35x
- Price / sales
- 1.77x
- Price / cash flow
- -46.06x
Enterprise value
- Enterprise value
- $772.2M
- EV / sales
- 1.71x
- EV / EBITDA
- -31.27x
- EV / EBIT
- -21.78x
- Market cap
- $797.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026